CAS Number5536-17-4
SynonymsVidarabine; adenine arabinoside; ara-adenosine; MFCD00065471; 9-(β-D-Arabinofuranosyl)-9H-purin-6-amine; 9-(b-D-Arabinofuranosyl)adenine; 9-β-D-arabinofuranosyl-9H-purin-6-amine; ara-A; 6-Amino-9-b-D-arabinofuranosylpurine; EINECS 226-893-9; Adenine-β-D-arabinofuranoside; 9-β-Arabinoadenosine; 9-(β-D-arabinofuranosyl)-9H-adenine; 9-(β-D-glycero-Pentofuranosyl)-9H-purin-6-amine; 6-Amino-9-β-D-arabinofuranosylpurine; araA; Vidarabine Monohydrate; 9-β-D-Arabinofuranosyladenine
Molecular FormulaC10H13N5O4
Molecular Weight267.24
Purity≥99%
Density2.1±0.1 g/cm3
Boiling Point676.3±65.0 °C at 760 mmHg
Melting Point260-265ºC (dec.)
Appearancepowder
EINECS226-893-9
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 5536-17-4 |
| Catalog No. | 2A-9007038 |
| Chinese Name | 阿糖腺苷 |
| Synonyms | Vidarabine; adenine arabinoside; ara-adenosine; MFCD00065471; 9-(β-D-Arabinofuranosyl)-9H-purin-6-amine; 9-(b-D-Arabinofuranosyl)adenine; 9-β-D-arabinofuranosyl-9H-purin-6-amine; ara-A; 6-Amino-9-b-D-arabinofuranosylpurine; EINECS 226-893-9; Adenine-β-D-arabinofuranoside; 9-β-Arabinoadenosine; 9-(β-D-arabinofuranosyl)-9H-adenine; 9-(β-D-glycero-Pentofuranosyl)-9H-purin-6-amine; 6-Amino-9-β-D-arabinofuranosylpurine; araA; Vidarabine Monohydrate; 9-β-D-Arabinofuranosyladenine |
| Molecular Formula | C10H13N5O4 |
| Molecular Weight | 267.24 |
| Purity | ≥99 |
| Density | 2.1±0.1 g/cm3 |
| Boiling Point | 676.3±65.0 °C at 760 mmHg |
| Melting Point | 260-265ºC (dec.) |
| Appearance | powder |
| Storage Condition | -20℃ Avoid light, keep in a cool and dry place, se |
| Packaging | II |
| Application | Vidarabine is a nucleoside antibiotic isolated from Streptomyces and is effective against herpes simplex and varicella-zoster viruses. |
| EINECS | 226-893-9 |
| HTC | 29349990 |
| PubChem ID | 24891019 |
| MDL Number | MFCD00065471 |
| SMILES | Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O |
| InChI | 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7+,10-/m1/s1 |
| InChI Key | OIRDTQYFTABQOQ-UHTZMRCNSA-N |
| Beilstein/REAXYS | 624881 |
| NACRES Code | NA.77 |
| UNSPSC | 12352202 |
| Hazard Symbols | 6.1(a) |
| Risk Codes | R63 |
| Safety Description | S36/37 |
| MSDS | msds/7038_1_5536_17_4.pdf |
| Bioactivity | Vidarabine is an antiviral drug which is active against herpes simplex and varicella zoster viruses.Target: DNA/RNA SynthesisVidarabine is a nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the vaccinia VIRUS and varicella zoster virus [1]. Related Catalog Signaling Pathways >> Anti-infection >> HSV Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog Research Areas >> Infection References [1]. Whitley, R., et al., Vidarabine: a preliminary review of its pharmacological properties and therapeutic use. Drugs, 1980. 20(4): p. 267-82. Chemical & Physical Properties Density 2.1±0.1 g/cm3 Boiling Point 676.3±65.0 °C at 760 mmHg Melting Point 260-265ºC (dec.) Molecular Formula C10H13N5O4 Molecular Weight 267.241 Flash Point 362.8±34.3 °C Exact Mass 267.096741 PSA 139.54000 LogP -1.02 Vapour Pressure 0.0±2.2 mmHg at 25°C Index of Refraction 1.907 InChIKey OIRDTQYFTABQOQ-UHFFFAOYSA-N SMILES Nc1ncnc2c1ncn2C1OC(CO)C(O)C1O |
| Use of | Vidarabine is an antiviral drug which is active against herpes simplex and varicella zoster viruses.Target: DNA/RNA SynthesisVidarabine is a nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the vaccinia VIRUS and varicella zoster virus [1]. Properties Articles86 Name adenine arabinoside Synonym More Synonyms Vidarabine Biological Activity Description Vidarabine is an antiviral drug which is active against herpes simplex and varicella zoster viruses.Target: DNA/RNA SynthesisVidarabine is a nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the vaccinia VIRUS and varicella zoster virus [1]. Related Catalog Signaling Pathways >> Anti-infection >> HSV Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog Research Areas >> Infection References [1]. Whitley, R., et al., Vidarabine: a preliminary review of its pharmacological properties and therapeutic use. Drugs, 1980. 20(4): p. 267-82. Chemical & Physical Properties Molecular Formula C10H13N5O4 Exact Mass 267.096741 PSA 139.54000 LogP -1.02 Index of Refraction 1.907 InChIKey OIRDTQYFTABQOQ-UHFFFAOYSA-N |
| Transport Info | Product name: Purity: 99.0% |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special reminder to users No data available |
| Related Products in Heterocyclic Building Blocks | ||
|---|---|---|
| 8-Methylquinoline | 611-32-5 | 2A-9007028 |
| 8-Quinolinecarboxylic acid | 86-59-9 | 2A-9007029 |
| 9-(4-Acetoxymethylbut-1-yl)-2-amino-6-chloropurine | 2A-107031 | 2A-9007031 |
| 9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; Oxygen-fluorine acid | 82419-35-0 | 2A-9007033 |
| 9-[2-(Diethylphosphonomethoxy)ethyl]adenine | 116384-53-3 | 2A-9007036 |
| Adenine | 73-24-5 | 2A-9007070 |
| Adenine hydrochloride | 2922-28-3 | 2A-9007071 |
| Adenine hydrochloride hydrate | 6055-72-7 | 2A-9007072 |
| Adenine phosphate | 52175-10-7 | 2A-9007073 |
| Adenine sulfate | 321-30-2 | 2A-9007074 |
| Browse all Heterocyclic Building Blocks products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS